Metabolic-Fit / 100
Willow review
Unusually open about its clinicians and pharmacies — a named CMO, roughly forty-five named physicians, three named compounding pharmacies — and unusually loose about its advertising, having dropped 'comparable to FDA-approved semaglutide' claims only after the National Advertising Division referred it to the FTC.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Willow at a glance
- Semaglutide
- From $299/mo
- Tirzepatide
- From $399/mo
- Coverage
- 36 states
- Brand-name
- Compounded only
How we scored Willow
Every factor comes from Willow's own published pricing, disclosures and oversight, and the six combine into the 66/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- July 2026
- Confidence
- medium
- Primary source
- www.startwillow.com/faqs
$299/mo semaglutide and $399/mo tirzepatide, published openly on the product pages instead of behind a quiz — rarer in this market than it should be. Two things to settle before you start: the fee moves with your dose, by Willow's own terms, and it operates in 36 states rather than all fifty.
What to expect when you sign up
We walked Willow's public signup funnel (July 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Every price is public on its own product page — no quiz, no email gate, no account needed
- 2Step 1 of the funnel asks your state from a dropdown listing all 50; there is no warning beforehand that Willow serves only 36, and unsupported states are bounced to a waitlist page only after you submit
- 3Supported states move to name and personal details, then a health-history form — 'you'll share your health, lifestyle, and medical history in a short online form'
- 4A licensed physician reviews the form asynchronously and, if eligible, prescribes; Willow advertises same-day approval, which only an async review makes possible
What we noticed
- Pricing is NOT flat: the Terms state the fee 'may be increased or decreased if your prescription changes, such as by a dosage increase', and the FAQ hedges that 'medication costs vary by dosage and prescription' — the flat-$299 claim circulating on review sites is not supported by Willow's own documents
- Three compounding pharmacies ARE named in the Terms — Red Rock Home Pharmacy (UT), Epiq Pharmacy (TX) and The Pharmacy Hub (FL) — with addresses and phone numbers, which is well above average disclosure
- A named Chief Medical Officer (Dr. Michael Green, MD) and roughly forty-five individually named physicians with bio pages — most competitors on this roster name nobody
- Three DIFFERENT cancellation windows appear across three Willow pages: 'at least 2 business days' in the FAQ, 'two (2) full calendar days' in the Terms, and refunds only 'within 24 hours of order placement' in the Informed Consent
- Labs and bloodwork are never mentioned anywhere on the site — not included, not offered, not required — and there is no coaching or dietitian benefit
- The Terms are dated 11.24.2021 and still describe the business as 'women's health services', and the cancellation contact URL they point to is dead
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $299 | InjectionPosted publicly at /compound-semaglutide, no quiz required. A semaglutide + B12 blend is offered at the same $299. Treat it as a STARTING price: the Terms say the fee 'may be increased or decreased if your prescription changes, such as by a dosage increase'. |
| Compounded tirzepatide | $399 | InjectionPosted publicly at /compound-tirzepatide. Also dose-scaled rather than flat. |
| Oral semaglutide | $299 | Sublingual tablet, needle-freePosted at /semaglutide-tablets — a daily under-the-tongue tablet at the same price as the injection. |
| Oral tirzepatide | $399 | Sublingual tablet, needle-freePosted at /tirzepatide-tablets. Note Willow's own FAQ says the oral option is 'Semaglutide only', contradicting this live product page — one of several internal inconsistencies on the site. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Willow's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Both molecules offered as sublingual tablets as well as injections — a genuinely uncommon menu
- Names a Chief Medical Officer and roughly forty-five individual physicians with bio pages, plus three compounding pharmacies with addresses — far more disclosure than most of this roster
- Every price is posted publicly per product, with no quiz, email gate or account required
- The plan price bundles medication, the medical evaluation, unlimited physician messaging and free shipping, with no additional fees stated
The caveats
- Dropped claims that its compounded semaglutide was 'comparable to FDA-approved' products and produced weight loss 'without diet or exercise' only after the National Advertising Division referred it to the FTC and state attorneys general
- The fee scales with your dose — $299 and $399 are starting prices, and no per-dose table is published anywhere
- Three different cancellation windows appear across three of its own pages: two business days, two calendar days, and 24 hours from order
- Available in 36 states, but the signup form offers all fifty and only rejects you after you submit
- No lab work is mentioned anywhere on the site, and there is no coaching or dietitian benefit
- Its Terms are dated 2021, still describe the business as 'women's health services', and point cancellations at a dead URL
- Sublingual GLP-1 tablets are far less studied than the injectables the pivotal trials used
- Breastfeeding appears only as an exclusion criterion, and there is no postpartum content at all
The most open provider here about who, and the loosest about what
Willow publishes more about itself than almost anyone on this roster. A named Chief Medical Officer. Roughly forty-five individual physicians with bio pages. Three compounding pharmacies, with addresses. Every price posted publicly, per product, with no quiz, no email gate and no account required. If you have read a dozen of these pages and grown tired of "a network of licensed providers" and "contact us for pricing", this is the opposite of that, and it is genuinely to Willow's credit.
And it dropped claims that its compounded semaglutide was "comparable to FDA-approved" products, and produced weight loss "without diet or exercise", only after the National Advertising Division referred it to the FTC and state attorneys general. Both of those things are true about the same company. Being unusually forthcoming about your clinicians and unusually loose about your claims are not opposites — and a reader deciding tonight needs both, not an average of them.
The price moves with your dose, and the starting figure is a floor
Semaglutide starts at $299 a month and tirzepatide at $399, injection or sublingual tablet. Those are starting prices: by Willow's own terms the fee scales with your dose, and no per-dose table is published anywhere. So the figure you see is the figure at the bottom of the ladder, and the one you will actually pay at a maintenance dose is not published at all.
That is worth pricing honestly before you start, because titration is not optional — it is how these medications are meant to be taken. Ask what the fee is at the dose you expect to reach, not at the one you begin on.
- Semaglutide: from $299/mo — injection or needle-free sublingual tablet
- Tirzepatide: from $399/mo — injection or sublingual tablet
- Included: medication, the medical evaluation and unlimited follow-up in the plan price
- Disclosed: a named CMO, ~45 named physicians, three named pharmacies with addresses
- Coverage: 36 states, not all fifty
Three cancellation windows, on three of its own pages
Willow states three different cancellation windows across three different pages of its own site. That is not a trap so much as a mess, but it has the same effect on you: if you need to stop, the terms you are held to are whichever ones the company decides apply. Get the cancellation window confirmed in writing, from a person, before the first charge — and keep the reply.
Who this suits
Someone who values knowing exactly which physician and which pharmacy stands behind her prescription, wants a needle-free tablet option, and lives in one of the 36 states served. Go in knowing the advertised price is a floor that rises with your dose, and settle the cancellation terms first. The disclosure here is real and unusually good; the advertising history is the reason to read the fine print anyway.
The bottom line for mothers
Best for: Mothers in one of its 36 states who want a sublingual GLP-1 rather than a weekly injection, value knowing exactly which doctor and which pharmacy are behind the prescription, and will get the price at their target dose in writing.
Alternatives to Willow
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Willow
Head-to-head & alternatives
Willow, answered
- Does Willow really offer GLP-1 tablets instead of injections?
- Yes — Willow sells sublingual semaglutide and tirzepatide tablets on their own product pages, alongside the usual injections. For a mother who has been putting this off because of the needle, that is a real reason to look. Set expectations honestly, though: these are compounded sublingual formulations, and that route is far less studied than the weekly injection the pivotal trials used, so the published outcome numbers do not automatically carry over.
- What does Willow actually cost per month?
- Semaglutide is $299 a month and tirzepatide $399, injection or sublingual tablet, all posted openly without a quiz — which is more transparency than most of this market offers. The catch is that these are starting prices. Willow's Terms say the fee 'may be increased or decreased if your prescription changes, such as by a dosage increase', and its FAQ adds that costs 'vary by dosage and prescription'. So the flat-$299-at-every-dose claim you may have read elsewhere is not what Willow's own documents say. No per-dose table is published, and there is no intro or first-month rate on its site. Get your target dose quoted in writing.
- Is Willow available in my state?
- Willow lists 36 states in its FAQ. Worth knowing before you start: the signup form opens with a dropdown of all fifty, with no warning about limits — enter an unsupported state and you are bounced to a waitlist page after submitting. One note if you are comparing sources: some affiliate directories carry an 18-state exclusion list for Willow that is wrong on four. Maine, Massachusetts, Tennessee and Wyoming are all served — we confirmed that both in Willow's published list and by walking the live state gate. Washington DC, which those directories imply is available, is not served.
- Has Willow been in trouble over its advertising?
- Yes, and it is recent enough that you should know. After a challenge by Novo Nordisk, the National Advertising Division recommended in December 2025 that Willow drop or modify safety and efficacy claims for its compounded semaglutide. Willow refused, and NAD referred the matter to the FTC and state attorneys general. In July 2026 Willow returned to NAD following discussion with the FTC and voluntarily dropped the claims — including that its products were comparable to FDA-approved semaglutide and produced weight loss without diet or exercise. In fairness, this concerns marketing language rather than any finding about the medication, and a separate Eli Lilly suit against Willow was dismissed with prejudice in February 2026. But a company that had to be walked to the FTC before withdrawing 'no diet or exercise' claims is telling you something about how it sells.
- Does Willow handle postpartum or breastfeeding timing?
- No. Willow states it is available to adults who are 'not pregnant or breastfeeding' — that is an exclusion, not guidance — and it publishes nothing on postpartum care at all. There is a single PCOS article and no PCOS program behind it. The practical points still apply: semaglutide's labeling asks for a two-month stop before a planned pregnancy, tirzepatide carries no such washout, and the injectable labels do not prohibit breastfeeding — they record that there are no human-milk data and ask you and your clinician to weigh it. If timing around nursing is your real question, a provider whose clinicians will discuss it fits better.
Pricing, states and verification reflect Willow's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.